Experts Discuss Evolving State-of-the-Art Management of Patients With HER2-Positive MBC
Listen to breast cancer experts Thomas Bachelot, MD, PhD; Adam M. Brufsky, MD, PhD; and Cristina Saura, MD, PhD, discuss 2 real-world cases of patients with HER2-positive MBC and clinical considerations in the evolving state-of-the-art care treatment landscape.
Decera Clinical Education Oncology Podcast · Cristina Saura MD PhD, Thomas Bachelot MD PhD, Adam M. Brufsky MD PhD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, listen to breast cancer experts Thomas Bachelot, MD, PhD; Adam M. Brufsky, MD, PhD; and Cristina Saura, MD, PhD, discuss clinical considerations for patients with HER2-positive MBC, with topics including:
- Local therapy in the context of MBC
- Choice of therapy after progression on available standards of care
- Choice of trastuzumab deruxtecan and tucatinib based on patient presentation
- Managing patients with CNS metastases
- Managing interstitial lung disease
Presenters:
Thomas Bachelot, MD, PhD
Chair, Unicancer Breast Group - UCBG
Breast Cancer Unit
Medical Oncology
Centre Léon Bérard
Lyon, France
Adam M. Brufsky, MD, PhD
Professor of Medicine
Hematology/Oncology
University of Pittsburgh School of Medicine
Associate Chief, Hematology-Oncology
University of Pittsburgh Cancer Institute
Pittsburgh, Pennsylvania
Cristina Saura, MD, PhD
Medicine and Surgery/Medical Oncology
Universidad Universitat Autònoma Barcelona and Vall d’Hebron Institute of Oncology (VHIO)
Head, Breast Cancer Program
Medical Oncology
Vall d’Hebron University Hospital
Barcelona, Spain
Content based on an online CME program supported by an educational grant from Daiichi Sankyo, Inc.
Link to full program, including associated downloadable slidesets:
https://bit.ly/32A1HMb
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.